Boehringer Ingelheim

For Healthcare Professionals

Contact Us

Malaysia | EN
Australia | EN
Korea | KR
New Zealand | EN
Philippines | EN
Singapore | EN
Thailand | EN
Vietnam | VN

Boehringer Ingelheim

Boehringer Ingelheim

Boehringer Ingelheim

Products
- Malaysia | EN
- Australia | EN
- Korea | KR
- New Zealand | EN
- Philippines | EN
- Singapore | EN
- Thailand | EN
- Vietnam | VN
Malaysia | EN
Contact Us

Malaysia | EN
Australia | EN
Korea | KR
New Zealand | EN
Philippines | EN
Singapore | EN
Thailand | EN
Vietnam | VN

Boehringer Ingelheim

All Specialties
Cardiology
Nephrology
Endocrinology
Primary Care
Prescribing Information

How do SGLT2 inhibitors protect the heart and kidneys in addition to providing glucose control?

Home
All Specialties
Patient Materials
How do SGLT2 inhibitors protect the heart and kidneys in addition to providing glucose control?

Related content

Document ID: NP-MY-100079

Lee-Ling Lim (Malaysia)

Why is organ protection crucial in patients with cardiorenal metabolic conditions?

Watch now Opens in new tab

PDF

How can you get the most out of SGLT2 inhibitors?

Read more Opens in new tab

PDF

Type 2 diabetes guideline

Read more Opens in new tab

PDF

SADMANS guide: Sick day rules to protect patients during acute illness

Read more Opens in new tab

PDF

Checklist for managing people with type 2 diabetes

Read more Opens in new tab

BI logo

Accessibility Statement
Terms of Use
Sitemap
Privacy Policy

Products discussed herein may have different labeling in different countries. Use of this site is subject to the Internet Site Legal Notices and Disclaimers and Privacy Notice.

© 2010-2025 Boehringer Ingelheim GmbH All rights reserved

Did you find what you were looking for?

Yes

No

Your feedback submitted Successfully !

Leave this field blank